000 01584 a2200457 4500
005 20250517202307.0
264 0 _c20180816
008 201808s 0 0 eng d
022 _a1744-8301
024 7 _a10.2217/fon-2017-0451
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDeLeon, Thomas T
245 0 0 _aNovel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
_h[electronic resource]
260 _bFuture oncology (London, England)
_cMar 2018
300 _a553-566 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBiliary Tract Neoplasms
_xdiagnosis
650 0 4 _aBiomarkers, Tumor
650 0 4 _aCarcinoma, Hepatocellular
_xdiagnosis
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGenetic Variation
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xdiagnosis
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aSignal Transduction
650 0 4 _aTreatment Outcome
700 1 _aAhn, Daniel H
700 1 _aBogenberger, James M
700 1 _aAnastasiadis, Panos Z
700 1 _aArora, Mansi
700 1 _aRamanathan, Ramesh K
700 1 _aAqel, Bashar A
700 1 _aVasmatzis, George
700 1 _aTruty, Mark J
700 1 _aOklu, Rahmi
700 1 _aBekaii-Saab, Tanios S
700 1 _aBorad, Mitesh J
773 0 _tFuture oncology (London, England)
_gvol. 14
_gno. 6
_gp. 553-566
856 4 0 _uhttps://doi.org/10.2217/fon-2017-0451
_zAvailable from publisher's website
999 _c28102753
_d28102753